Lv7
4930 积分 2022-11-07 加入
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy
4小时前
待确认
ABCL-412 Clinical Activity of CC-99282, a Novel, Oral, Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) –Results From CC-99282-NHL-001 (NCT03930953) a First-in-Human, Phase 1, Open-Label, Multicenter Study
1个月前
已关闭
Escape from Protacs®: Recent Developments in Protein Degradation With Small-Molecule Glues
1个月前
已关闭
Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores
1个月前
已完结
P164 MRT-6160, a VAV1-directed molecular glue degrader, inhibits disease progression and inflammation in a T-cell transfer model of Colitis
1个月前
已完结
POS1200 MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL
1个月前
已关闭
P164 MRT-6160, a VAV1-directed molecular glue degrader, inhibits disease progression and inflammation in a T-cell transfer model of Colitis
1个月前
已完结
Redox-neutral organocatalytic Mitsunobu reactions
1个月前
已完结
Universal Reagent for Mild and Stereospecific Nucleophilic Substitution of Alcohols with Amines
1个月前
已完结
Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA
2个月前
已完结
皖公网安备34019202002308
